BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29699729)

  • 1. PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia.
    Maugeri G; D'Amico AG; Rasà DM; Saccone S; Federico C; Cavallaro S; D'Agata V
    Neuropeptides; 2018 Jun; 69():84-91. PubMed ID: 29699729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of A
    Maugeri G; D'Amico AG; Federico C; Saccone S; Giunta S; Cavallaro S; D'Agata V
    J Mol Neurosci; 2019 Sep; 69(1):166-176. PubMed ID: 31166001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP and VIP Inhibit HIF-1α-Mediated VEGF Expression in a Model of Diabetic Macular Edema.
    Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Physiol; 2017 May; 232(5):1209-1215. PubMed ID: 27661459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory role of PACAP and VIP on HIFs expression in lung adenocarcinoma.
    D'Amico AG; Maugeri G; Rasà DM; Reitano R; Saccone S; Federico C; Magro G; D'Agata V
    Peptides; 2021 Dec; 146():170672. PubMed ID: 34627957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells.
    de Boisvilliers M; Perrin F; Hebache S; Balandre AC; Bensalma S; Garnier A; Vaudry D; Fournier A; Festy F; Muller JM; Chadéneau C
    Peptides; 2016 Apr; 78():30-41. PubMed ID: 26826611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells.
    Falktoft B; Georg B; Fahrenkrug J
    Neuropeptides; 2009 Oct; 43(5):387-96. PubMed ID: 19712974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide promote the genesis of calcium currents in differentiating mouse embryonic stem cells.
    Chafai M; Basille M; Galas L; Rostene W; Gressens P; Vaudry H; Gonzalez BJ; Louiset E
    Neuroscience; 2011 Dec; 199():103-15. PubMed ID: 22001490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
    Eggenberger M; Born W; Zimmermann U; Lerner EA; Fischer JA; Muff R
    Neuropeptides; 1999 Apr; 33(2):107-14. PubMed ID: 10657479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression.
    Maugeri G; D'Amico AG; Reitano R; Magro G; Cavallaro S; Salomone S; D'Agata V
    Front Pharmacol; 2016; 7():139. PubMed ID: 27303300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout.
    Le Mével JC; Lancien F; Mimassi N; Conlon JM
    J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas.
    Vertongen P; Devalck C; Sariban E; De Laet MH; Martelli H; Paraf F; Hélardot P; Robberecht P
    J Cell Physiol; 1996 Apr; 167(1):36-46. PubMed ID: 8698838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
    Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis.
    Isobe K; Kaneko M; Kaneko S; Nissato S; Nanmoku T; Takekoshi K; Okuda Y; Kawakami Y
    Regul Pept; 2004 Dec; 123(1-3):29-32. PubMed ID: 15518890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.
    Poomthavorn P; Wong SH; Higgins S; Werther GA; Russo VC
    Endocr Relat Cancer; 2009 Sep; 16(3):991-1004. PubMed ID: 19423615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.